AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
Clinical trial NCT03317002 · COMPLETED
Trial details
- NCT number
- NCT03317002
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2020-04-08
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.